Ocular Therapeutix (OCUL) Change in Acquisitions & Divestments (2015 - 2017)

Ocular Therapeutix's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $3.0 million for Q3 2017.

• In Q3 2017, Change in Acquisitions & Divestments fell 79.57% year-over-year to $3.0 million; the TTM figure through Dec 2017 stood at $38.2 million (down 52.65% YoY), while the FY2017 annual figure was $38.2 million, down 52.65% from the prior year.
• Change in Acquisitions & Divestments was $3.0 million for Q3 2017 at Ocular Therapeutix, down from $22.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $30.0 million in Q3 2015 to a low of $3.0 million in Q3 2017.
• Historically, Change in Acquisitions & Divestments has averaged $18.2 million across 3 years, with a median of $16.0 million in 2016.
• The sharpest annual moves came in 2016 and 2017: Change in Acquisitions & Divestments climbed 6.67% in 2016, then sank 79.57% in 2017.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $15.0 million in 2015, then climbed by 6.67% to $16.0 million in 2016, then sank by 81.25% to $3.0 million in 2017.
• The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2017), $22.7 million (Q2 2017), and $12.5 million (Q1 2017), per Business Quant data.